The Hunt for the Next 10 Bagger

[Blue54]

NFRX nice forecast

Here's a nice forecast .... Link http://www.cpreports.com/?p=861

You Are Here: Home » CP Reports Blog » RAY DIRKS Research: NFRX.pk Feb 8, 2011 by Ray Dirks

RAY DIRKS Research: NFRX.pk Feb 8, 2011 by Ray Dirks
Posted on admin on February 9, 2011 // Leave Your Comment InferX Corporation (NFRX.pk) – $0.60

February 7, 2011

RAY DIRKS Research recommends InferX Corporation (NFRX.pk) at its current price of 60 cents per share for substantial capital appreciation over the next 6 months, 1 year, 3 years, and 5 years. Headquartered in Northern Virginia near the Dulles International airport, InferX’s top management team and its 25 full-time employees plus 30 consultants are capable of leading the accelerating worldwide trend of Predictive Analysis (PA) by utilizing its 6 key patents (2 granted and 4 pending) in such significant areas as healthcare, insurance, government, finance, retail, and sales and marketing of industrial products.

Specifically, RAY DIRKS Research believes that the common stock of InferX will appreciate by 100% within 3 months to $1.20, triple within 1 year to $1.80, appreciate by 10 times within 3 years to $6.00, and by 20 times within 5 years to $12.00 per share.

Because InferX is pioneering a next-generation technology and currently has modest revenues, we recommend that investors commit no more than 1 percent of their equity portfolio to NFRX common shares. Just last week InferX stock advanced sharply because of an announcement concerning a significant contract.

Summary Financial Table for InferX (NFRX.ob):
Current Price $0.60
Target Price May 10, 2011 $1.20
Target Price February 10, 2012 $1.80
Target Price February 10, 2014 $6.00
Target price February 10, 2016 $12.00
Shares Outstanding 17.3 million
Shares Fully Diluted 29.4 million
Market Capitalization $ 10.4 million
Est. Earnings per Share – 2011 $ -0.02
Est. Cash Flow per Share – 2011 $ 0.01

InferX (NFRX) is a market leader in next-generation distributed Predictive Analytics (PA) software solutions. InferX pioneered and commercialized a powerful, patented group of advanced analytical solutions which direct decision making and improve corporate performance. InferX targets its sophisticated solution toward select sub-sectors in the healthcare, public sector, industrial product, retail, and financial service industries in order to address significant Return on Investment opportunities.

PA enterprise software solutions directs decision making by applying advanced analytics and decision organization to a client organization’s enterprise data, with the objective of improving the client’s business processes to meet its specific organization goals. The PA solution accomplishes this through the application of advanced algorithms that process historical data, “learn” what has occurred in the past, and create “real time” business decisions within the client’s organization.

Traditional business intelligence (BI) tools extract relevant data in a structured way, aggregate and present it in formats such as dashboards and reports. BI tools are more exploratory than decision-oriented, helping businesses understand performance and trend, but generally not directing future actions or decisions based on what has been observed. Any attempts at using BI platforms to offer predictive insights are based on “deductive” technology (i.e., regression analysis) where “experts” create initial rules or hypotheses about the patterns and relationships that exist within the data based on their personal experience (i.e., who is a credit risk, what parameters create a potential risk, what medical indicators suggest a possible adverse drug reaction, etc.). Therefore, decisions based on a deductive approach are only as good as the initial rules, hypotheses, or data variables that directed the analysis.

By contrast, Predictive Analysis enterprise software solutions are based on “inductive” technology. PA does not presume initial rules or hypotheses about patterns and relationships that could exist within the data. Rather, PA lets data lead the way and employs statistics, machine learning, neural computing, robotics, computational mathematics, and artificial intelligence techniques to explore all the data, instead of utilizing a narrow subset of it, to ferret out meaningful relationships and patterns. This approach allows PA to identify insights and relationships among different variables, particularly ones that are outside conventional thinking.

InferX’s next-generation PA solution differentiates itself from traditional PA solutions in that it operates best in a distributed data environment. Instead of having to move data from different locations and servers into data warehouses to perform analysis, the next generation distributive PA solution brings the analysis directly to the data. InferX’s distributed solution is patented and enhances analytical speed, data privacy, and security while reducing cost.

In 2009, InferX merged with the Irus Group, a BI consulting and services firm specializing in the planning, implementation, and development of complex BI and corporate performance management solutions for government, financial services, retail, and healthcare clients. Since its founding, Irus Group has conducted engagements for over 200 clients, including Master Card, JPMorgan Chase, ConAgra, US Navy, US Army, US Air Force, and Peace Corps. The merger provides InferX additional financial support in advance of the full roll-out of InferX’s enterprise software solutions, and it serves as a valuable source of sales leads for the PA enterprise software product.

Disclosure:
The information contained in this Report contains forward-looking statements relating to the developments of the featured company’s products, services and future operating results or the future of the market. Statements contained in writing or in interviews are subject to certain risks and uncertainties that could cause actual results to differ materially from those projected.

The words “believe,”, “expect,” “intend,” “anticipate,” variations of such words, and similar expressions identify forward-looking statements, but their absence does not mean that the statement is not forward-looking. These statements are not guarantees of future performance and are subject to certain risks, uncertainties and assumptions that are difficult to predict. Factors that could affect performance include, but are not limited to, those factors that are discussed in each Company’s most recent reports and/or registration statements filed with the Securities and Exchange Commission. Visitors to this Internet Site are cautioned not to place undue reliance on these forward-looking statements. These statements have not been independently verified by the officers, directors or employees of Corporate Profile, LLC .com.

The information on this Internet Site has been submitted by journalists and analysts or provided by the companies contained herein or other sources believed to be reliable. Corporate Profile, LLC has not independently verified the information provided to it by third parties. Each individual should perform his or her own independent analysis before investing. The information contained herein is neither an offer nor a solicitation to buy any of the securities of the companies contained herein. Investing in securities is speculative and contains a high element of risk.